ArticleAntioxidants (Basel, Switzerland)2026

Microbial Metabolism of Levodopa as an Adjunct Therapeutic Target in Parkinson's Disease.

Jimmy B Feix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.